Eicosanoids Lecture Notes PDF
Document Details
Uploaded by SeamlessCanto
SMC, JSMU
Tags
Summary
These lecture notes provide an overview of Eicosanoids, covering their roles in the body. It discusses their classification, synthesis, and functions in various physiological processes. The lecture notes also touch upon the effects of eicosanoids and the use of drugs to inhibit their synthesis.
Full Transcript
# Eicosanoids ## Objectives At the end of the lecture, students should be able to discuss: - Eicosanoids - Cyclooxygenase - Lipoxgenase - Biological effect on different tissues - Therapeutic effects - Inhibition of eicosanoid ## Eicosanoids - Derived from 20-carbon polyunsaturated fatty acids -...
# Eicosanoids ## Objectives At the end of the lecture, students should be able to discuss: - Eicosanoids - Cyclooxygenase - Lipoxgenase - Biological effect on different tissues - Therapeutic effects - Inhibition of eicosanoid ## Eicosanoids - Derived from 20-carbon polyunsaturated fatty acids - Paracrine or autocrine messenger molecules - Short half-lives (10 seconds - 5 minutes) so that functions are usually limited to actions on nearby cells. - Bind to specific cell surface G-protein coupled receptors, and generally increase cAMP levels. May also bind to nuclear receptors and alter gene transcription. ## Eicosanoids Classification Eicosanoids are classified into two main groups: - Prostanoids - Leukotrienes and Lipoxins Prostanoids are further sub-classified into three groups: - Prostaglandins (PGs) - Prostacyclins (PGIs) - Thromboxanes (TXs) ## Inflammatory Biomolecules - **Histamine** - Made in almost all tissues - Very short half-life - Act locally on neighbors - Not usually stored up - 20-carbon backbones - Made from arachidonic acid - **Eicosanoids** - Prostaglandins - Thromboxanes - Leukotrienes - **Bradykinins** - **Cytokines** - Interferons - Interleukins - Chemotaxins - Other minor molecules... ## Eicosanoids Synthesis - **Arachidonic acid** - **TXA2** (E,I,F,D) - **PGs** (E,I,F,D) - **LTB4** (C,D,E) - **LTS** (C,D,E) ## Role of Eicosanoids - Prostaglandins, Prostacyclins, Thromboxanes, Leukotrienes, Epoxyeicosatrienoic acids - They have roles in: - Inflammation - Fever - Regulation of blood pressure - Blood clotting - Immune system modulation - Control of reproductive processes & tissue growth - Regulation of sleep/wake cycle ## Effects of Eicosanoids - Induction of inflammation - Mediation of pain signals - Induction of fever - Smooth muscle contraction (including uterus) - Smooth muscle relaxation - Protection of stomach lining - Stimulation of platelet aggregation - Inhibition of platelet aggregation - Sodium and water retention ## Precursors of Eicosanoids - Arachidonic acid (ω6) - Eicosatrienoic acid (γ-linolenic acid, ω6) - Eicosapentaenoic Acid (ω3) ## Pathways of Arachidonic Acid (AA) Release and Metabolism - **Free radicals** - **Phospholipase A2** - **Isoprostanes** - **Arachidonic acid (20:4 cis D5,8,11,14)** - **Lipoxygenases (LOX)** - HETEs - Leukotrienes - Lipoxins - **Cyclooxygenases (COX)** - Prostaglandins - Prostacyclin - Thromboxane - Prostanoids ## Classification - **Cyclooxygenase Pathway** - Prostaglandins - Thromboxanes - Prostacyclins - **Lipoxygenase Pathway** - Leukotrienes - HETES ## Cyclooxygenase (COX) Pathway The cyclooxygenase pathway is a major pathway for the metabolism of arachidonic acid. It is responsible for the production of prostaglandins, prostacyclins, and thromboxanes. **COX-1** - Constitutive - The prostaglandins associated with are: - GI mucosal integrity - Platelet function - Renal function **COX-2** - Inducible - The prostaglandins associated with are: - Gain - Fever - Inflammation ## Prostaglandins (PGs) Prostaglandins are a group of eicosanoids that are produced by the cyclooxygenase pathway. They have a wide range of physiological effects, including: - Inflammation - Pain - Fever - Blood clotting - Vasodilation - Vasoconstriction **Prostaglandins (PGs)** - PG-G and H - PG-F - PG-A - PG-B - PG-E - PG-C and D ## Synthesis of Eicosanoids - **Phospholipid membrane** - **NSAIDS** - **Phospholipase A2** - **Arachidonic acid** - **Cyclooxygenase** - **Prostaglandin H2** - **Thromboxanes** - **Prostaglandins** - **Lipoxygenase** - **Leukotriene A** - **Leukotriene B1** - **Leukotriene C4, D4, E4** ## Cyclooxygenase (COX) Pathway - Prostaglandin H synthase, present as two isoenzymes (PGHS-1/COX-1, PGHS-2/COX-2). - Each possessing two activities: - **Cyclooxygenase** - catalyzes addition of two molecules of $O_2$ to the arachidonic acid molecule, forming $PGG_2$. - **Hydroperoxidase** - converts the hydroperoxy function of $PGG_2$ to an OH group (of $PGH_2$). - The enzyme is also capable of self-catalyzed destruction. ## Effects of Prostaglandins - **Vascular** - Vasoconstrictors - $TXA_2$ - $PGF_{2α}$ - Vasodilators - \(PGI_2\) - \(PGE_2\) - **Gastrointestinal Tract** - Longitudinal muscle: \(PGE_2\), \(PGF_{2α}\) - Circular muscle: \(PGF_{2α}\), \(PGI_2\), relaxed by \(PGE_2\) - **Airways** - Relaxed: \(PGD_2\), \(PGE_1\), \(PGE_2\), \(PGI_2\) - Contracted: \(PGF_{2α}\), \(TXA_2\) ## Role of Prostaglandins - **Inflammation** - **Fever** - PGs induce fever by stimulating the thermoregulatory center in the brain. - **Pain** - PGs sensitize pain receptors to stimulation, as a result increase pain perception - **Swelling** - There is vasodilatation and increased capillary permeability induced by PGs which is responsible for swelling of the inflamed tissue. - **Erythema, wheal and Flare** is also induced by PGs like PGE and PGD2. - **PGD2** is considered an important mediator of anaphylaxis ## Effect on Smooth Muscle - **Intestinal** - \(PGE\) and \(PGF\) produce contraction of the longitudinal smooth muscles producing diarrhea, cramps and reflux of bile. - **Clinical Significance:** Diarrhea and abdominal cramps are the commonly observed as side effects of PGs. - **Bronchial** - \(PGFs\) contract and \(PGEs\) relax bronchial smooth muscles. - **Clinical Significance:** \(PGE_1\) and \(PGE_2\) are therapeutically used as bronchodilators. - **Vascular** - \(PGEs\) cause vasodilatation. - \(PGF_{2α}\), and \(PG A_2\) cause vasoconstriction. - **Clinical Significance:** Systemic blood pressure falls in response to PGEs and PGAS - **Uterine** - \(PGE_1\), \(PGE_2\) and \(PGF_{2α}\) cause uterine contractions. - **Clinical Significance:** - \(PGE_2\) is used for the induction of labor at or near term. - In higher dosage PGES are used as abortifacients in first and second trimester of pregnancy. - They are also responsible for causing dysmenorrhea ## Effect on Platelets - \(PGE_1\) cause inhibition of platelet aggregation. - **Clinical significance:** \(PGE_1\) has been used for harvesting and storage of blood platelets for therapeutic transfusion. - **Inhibition:** \(PGE_1\), \(PGI_2\) - **Aggregator:** \(TXA_2\) ## Blood - \(TXA_2\) - Is a potent inducer of platelet aggregation - \(PGI_2\) and \(PGE_2\) - Inhibit platelet aggregation - \(PGES\) - Induce erythropoiesis by stimulating the renal release of erythropoietin. - **5-HPETE** - Stimulates release of histamine - \(PGI_2\) and \(PGD\) - Inhibit histamine release ## Effect on Kidney - \(PGEs\) cause: - Increased renal plasma flow - Increased GFR - Increased diuresis - Natriuresis - Kaliuresis is also induced by the action of \(PGE_2\) - **Major one:** \(PGE_2\), \(PGI_2\) - \(GFR\) ↑ (vasodilator effect) - \(TXA_2\): renal vasoconstrictor may play a role in renal function? (inflammatory renal disease) ## Effect on Gastrointestinal Secretions - \(PGE_1\) and \(E_2\) inhibit gastric secretions and are required for maintaining the integrity of gastric mucosa. - The effect is opposite on the pancreatic and intestinal secretions. There is increase in the volume, enzyme and electrolyte content of the pancreatic and intestinal secretions in response to \(PGE_1\) - Watery diarrhea results in response to administration of \(PGE_1\). ## Effect on Endocrine Glands - \(PGEs\) have insulin-like effects. They inhibit lipolysis and the effects on carbohydrate metabolism are the same as insulin - \(PTH\) (Parathormone) like effects are also seen on bone metabolism by PGs. They mobilize calcium from bones producing hypercalcemia. - Thyrotropin-like effects are seen on the thyroid gland. - Steroidogenic effects are seen on the adrenal tissue. ## Female Reproductive System - **Abortion** - \(PGF_{2α}\), \(PGE_2\): oxytoxic and ripening and priming of the cervix - Dinoprostone (\(PGE_2\)) - Plasma \(t_{1/2}\): 2-2.5 minutes - Carboprost tromethamine (\(PGF_{2α}\)) - Drawback: pulmonary hypertension - **Facilitation of Labor** - Potency:\(PGE_2\) > \(PGF_{2α}\) - Side effect:\(PGF_{2α}\) > \(PGE_2\) ## Male Reproductive Organ - **Fertility?** \(PGE\), \(PGF\) - **Erectile Dysfunction:** - Alprostadil (\(PGE_1\)) - Intracavernosal injection - Urethral suppository - **Bone Metabolism:** - Increase bone turn over - **Eye** - \(PGE\), \(PGF\) - Increasing outflow of aqueous humor ## Immunological Response - \(PGES\) secreted by macrophages: - Modulate or decrease the functions of - \(T\) and \(B\) lymphocytes ## Prostacyclins and Thromboxanes - **Prostacyclins (PGI)** contain another ring between 6th and 9th carbon atoms. - **Thromboxanes (TX)** have a six-membered oxane ring. - There are three series for Thromboxanes as well as for Prostacyclins. ## Functions of Prostacyclins - Synthesized in the heart and vascular endothelial cells. - Inhibit platelet and leukocyte aggregation - Decrease T-cell proliferation, lymphocyte migration and secretion of IL-1α and IL-2 - Induce vasodilatation and production of cAMP - Prevent clot formation. ## Functions of Thromboxanes - Synthesized by platelets. - Induce platelet aggregation. - Promote vasoconstriction. - Lymphocyte proliferation - Bronchoconstriction and - Promote clot formation. ## Lipoxygenase (LOX) Pathway - **Leukotrienes** - Identified as LTs. - A family of conjugated trienes formed in leukocytes, platelets, and macrophages by the lipoxygenase pathway in response to both immunologic and nonimmunologic stimuli. ## Leukotrienes and Allergies - Leukotrienes are a hundred times more potent than histamine. - Histamine provided a rapid response to an allergen. - In the later stages, leukotrienes are principally responsible for inflammation, smooth muscle constriction, constriction of the airways, and mucous secretion form mucosal epithelium. ## Leukotriene - **Non-peptido Leukotriene (LTB4):** - Role Chemostatic agent (attract certain type of WBCs to fight infection). - Increased vascular permeability, T-cell proliferation, leukocyte aggregation, IL-1, IL-2, INF-γ - **Peptide Leukotriene (LTC4, LTD4, LTE4):** - Increased Bronchoconstriction, Vascular permeability, IFN-γ - Component of Slow Reaction Substances of Anaphylaxis (SRS-A) released from sensitized lung after immunologic reaction. - Mediator of asthma: constrict bronchi & increase mucus secretion. - Involve in immediate hypersensitivity (allergic reaction) and inflammation and heart attack. ## Slow-reacting Substance of Anaphylaxis (SRS-A) - Slow-reacting substance of anaphylaxis (SRS-A) is a mixture of leukotrienes C4, D4, and E4. - This mixture is a potent constrictor of the bronchial airway musculature. - These leukotrienes together with leukotriene B4 also cause vascular permeability. - Chemotaxis and activation of leukocytes and - Are important regulators in many diseases involving inflammatory or immediate hypersensitivity reactions, such as asthma. ## Blood Cell and Inflammation - **Chemoattractant:** - **Neutrophils:** LTB4, lipoxin A - **Eosinophils:** LTC4, LTD4 - **Heart and Smooth Muscle** - **Cardiovascular** - **Smooth Muscle Chemoattractant:** 12(S)-HETE - **Gastrointestinal:** LTB4 - **Airways:** LTC4, LTD4 - **Increased vascular permeability, mucus secretion** ## Lipoxins Lipoxins are produced mainly by leukocytes and platelets stimulated by cytokines (IL-4, TGF-β): - 5-lipoxygenase (5-LO) of neutrophils produces leukotriene LTA4 which enters platelets where it is converted by 15-LO to LXA4 or LXB4 - 15-LO of epithelial cells and monocytes forms 15-HPETE which becomes a substrate of 5-LO and epoxid hydrolase of leukocytes...transcellular biosynthesis ## Biological Roles of Lipoxins Unlike pro-inflammatory eicosanoids, lipoxins attenuate the inflammation and appear to facilitate the resolution of the acute inflammatory response. - Hypothesis: In the first phase of the inflammatory response, leukotrienes are produced (e.g. LTB4) → then, the level of PGs rises and PGs „switch" the syntheses from leukotriene production to the pathway which, in the 2nd phase, produces lipoxins promoting the resolution of inflammation. - Therefore, potential therapeutic use of LXs in the treatment of inflammatory diseases (glomerulonephritis, asthma) is being extensively studied. ## Mediators of Different Phases of Inflammation - **Injury** - Microbial - Physical - Immunological - Hypoxia/Reperfusion - **Acute Inflammation** - Infiltration of inflammatory cells - Vasodilation - Proliferation of resident cells - **Braking Signals, Resolution & Repair** - Clearance of inflammatory cells & debris - Restoration of parenchymal cells - Limit matrix accumulation ## Main Sites of Eicosanoid Biosynthesis - Endothelial cells - Leukocytes - Platelets - Kidney Unlike histamine, eicosanoids are NOT synthesized in advance and stored in granules – when needed, they can be produced very quickly from arachidonate released from membranes. ## Major Sites of Synthesis of Eicosanoids - **Thromboxane A2:** Platelets (thrombocytes) + Lungs - **PGI2:** Vascular Endothelial Cells (blood vessels) + Heart - **PGH2:** heart, Kidney, spleen etc - **Leukotrienes:** WBCs (leukocytes), mast cell, lungs, spleen, heart and brain ## Inhibition of Eicosanoid Synthesis - **Corticosteroids** - By producing annexins, lipocortins - Inhibiting phospholipase A2 - **NSAIDs** - Inhibition of COX activity - May increase the lipoxygenase activity? ## Anti-Inflammatory Drugs Inhibit Eicosanoid Synthesis - **NSAIDs** - **Membrane lipids** - **Steroids** - **Phospholipase A2** - **Arachidonic Acid** - **Cyclooxygenase:** Prostaglandins, thromboxanes - **Lipoxygenase:** Leukotrienes ## Prostanoids Therapeutic Uses - **Uterine Stimulation** - **Dinoprostone (PGE2):** - Prostin E2 vaginal suppositories used to induce abortion between 12th-20th gestational weeks - Prostin E2 oral tablets for elective induction of labor/obliged induction because of HTN, toxemia, intrauterine death - Treatment of duration ≤ 18 hours - **Prostin E2 vaginal gel** used for induction of labor at term or near term (1-2 mg intravaginal, repeated Q 6hrs according to response) ## Inducing Abortion - **Second Trimester:** - Infusion of carboprost tromethamine or - Administration of vaginal suppositories containing dinoprostone - **First Trimester:** - These prostaglandins are combined with mifepristone (RU486) ## Prostanoids Therapeutic Uses GIT - **Misoprostol (CYTOTEC)** is a synthetic methyl ester analogue of \(PGE_1\). - Used to prevent drug-induced gastric ulceration during NSAIDs, corticosteroid or anticoagulant therapy. - It can be used alone or in combination with antacids for duodenal ulcer treatment. - Not used for pregnant women or whom are planning pregnancy. ## Prostanoids Therapeutic Uses Platelet Aggregation - **Epoprostenol (PGI2):** - It is used as a heparin replacement in some hemodialysis patients. - Used to prevent platelet aggregation in extracorporal circulation systems. ## Maintenance of Ductus Arteriosus - Is produced by \(PGE_1\) [Prostin VR] infusion - \(PGE_1\) will maintain patency of the ductus arteriosus, which may be desirable before surgery. ## Impotence & Erectile Dysfunction - Alprostadil (\(PGE_1\)) can be injected directly into the corpus cavernosum or administered as a transurethral suppository to cause vasodilation and enhance tumescence. - Replaced by PDE-V inhibitors ## Leukotrienes Therapeutic Importance - LTs have no therapeutic uses, but LTs antagonists have: - Anti-asthma medications: - 5-Lipoxygenase Inhibitors, e.g., zileutin - Leukotriene-receptor antagonists; montelukast, & zafirlukast ## Adverse Effects of Eicosanoids - Local pain and irritation - Bronchospasm - Gastrointestinal disturbances: nausea, vomiting, cramping, and diarrhea.